NCT07001280View on ClinicalTrials.gov

A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

July 21, 2025

Primary Completion Date

August 31, 2028

Study Completion Date

August 31, 2030

Conditions
Hereditary Angioedemas
Interventions
OTHER

No intervention

No intervention will be administered as part of this study.

Trial Locations (1)

Unknown

RECRUITING

Charite, Berlin

Sponsors

Lead Sponsor

CSL Behring
All Listed Sponsors
lead

CSL Behring

INDUSTRY